GUANGZHOU BAIYUNSHAN PHARMACEUTICAL
(HKEX: 874)

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.

16.860 -

-0.090 (-0.53%)
Range 16.750 - 16.970   (1.31%)
Open 16.960
Previous Close 16.950
Bid Price 16.810
Bid Volume ('000) 24
Ask Price 16.860
Ask Volume ('000) 22
Volume ('000) 1,264
Value 21,283,032
Remark -
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events


Top Contributors

IAmPatrick avatar
9963
Followers 661
Posts 1601
USNews avatar
348
Followers 272
Posts 1283231

Loading Chart...

Please login to view stock data and analysis